Global shortage of ADHD drugs hitting NZ patients
A worldwide shortage of ADHD medicines could mean New Zealand patients will struggle to get their usual brand or be forced to ...
Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play
Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe ...
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the ...
Hereford Times2 小时
DVLA fine risk over 110 health conditions you must declare
Drivers could face £1,000 fines or even lose their driving licence if they do not declare one of 110 medical conditions, the DVLA has warned. According to the government website, there is a long list ...
A Glimpse Into The Expert Outlook On Jazz Pharmaceuticals Through 12 Analysts
Jazz Pharmaceuticals JAZZ has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Consensus Recommendation of “Buy” from ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned a consensus rating of “Buy” from the fifteen ratings ...